Discover what scientific evidence says, the real risks of excessive consumption, and how to use cannabis responsibly

Featuring Larissa Meneghel (lawyer and former Anvisa public servant), Paula Scanapieco (Mile Express), and Juliana Sousa (lawyer specialized in customs and criminal law)

Patient from SC obtains safe conduct to import seeds and cultivate 279 cannabis plants per year, with decision based on medical reports and support from the STJ for medicinal use

Groundbreaking study suggests that a microdose of LSD helped alleviate separation anxiety in an elderly female dog

Veterinarian argues that cannabis derivatives reduce stress and strengthen immunity in pigs and poultry; lack of regulation is still a hurdle

Case study using THC highlights advances in mobility, quality of life, and sleep

Understand everything about cannabidiol

New regulation could make the country a reference in the sector by 2026

Event at Uece brought together experts, family members, and researchers to discuss scientific evidence and innovations in the use of CBD in the treatment of autism

STJ Minister demands Union and Anvisa to execute the Action Plan for the medicinal cultivation of the plant

Research identifies cannabidiol (CBD) as a promising and sustainable alternative for controlling viral diseases in aquaculture, replacing the use of antibiotics

Public hearing discusses legal support for entities that cultivate and distribute cannabis for therapeutic purposes

Prohibition Partners' interactive platform offers real-time data on the European cannabis market, ushering in a new era for investors, regulators, and industry companies

Study by Johns Hopkins shows that legalization of cannabis does not increase use among young people and highlights flaws in current policies and tests on the plant

Spanish study shows that medicinal cannabis spray can significantly reduce spasticity in patients with chronic spinal cord injury refractory to conventional therapies

Bahian association expands the use of medicinal cannabis to treat alcohol and crack dependence, focusing on comprehensive care, support, and combating stigma

Groundbreaking program approved by the German government allows clinics to treat treatment-resistant depression with psilocybin, under medical supervision and without the need for individual authorization

New legislation regulates production, tracking, and distribution of low-THC products for therapeutic use

Swiss project “Züri Can” expands participation with over 900 volunteers to assess the impacts of legalized substance use

Revivid invested in the groundbreaking research of scientist and mother Micheline Donato, who turned her experience with her daughter's autism into a clinical study on the use of cannabis in adults.